These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25331411)

  • 1. [Pharmaceutical care of serious bleeding induced by tramadol-warfarin interaction: a case report].
    Dong SJ; Zhang T; Li Y; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):809-13. PubMed ID: 25331411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tramadol-warfarin interaction.
    Sabbe JR; Sims PJ; Sims MH
    Pharmacotherapy; 1998; 18(4):871-3. PubMed ID: 9692666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to improve anticoagulation with warfarin.
    Castro TA; Heineck I
    Ther Drug Monit; 2012 Apr; 34(2):209-16. PubMed ID: 22406649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction.
    Dumo PA; Kielbasa LA
    Pharmacotherapy; 2006 Nov; 26(11):1654-7. PubMed ID: 17064212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan.
    Ahmed NO; Osman B; Abdelhai YM; El-Hadiyah TMH
    Int J Clin Pharm; 2017 Aug; 39(4):769-773. PubMed ID: 28508324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
    Katada Y; Nakagawa S; Minakata K; Odaka M; Taue H; Sato Y; Yonezawa A; Kayano Y; Yano I; Nakatsu T; Sakamoto K; Uehara K; Sakaguchi H; Yamazaki K; Minatoya K; Sakata R; Matsubara K
    J Clin Pharm Ther; 2017 Oct; 42(5):591-597. PubMed ID: 28503837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR).
    Pourgholi L; Goodarzynejad H; Mandegary A; Ziaee S; Talasaz AH; Jalali A; Boroumand M
    Toxicol Appl Pharmacol; 2016 Oct; 309():37-43. PubMed ID: 27581200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.
    Meegaard PM; Holck LH; Pottegård A; Madsen H; Hallas J
    Dan Med J; 2012 Feb; 59(2):A4383. PubMed ID: 22293053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care.
    Ha NB; Yang K; Hanigan S; Kurtz B; Dorsch MP; Mak H; Nagel J
    Ann Pharmacother; 2016 Sep; 50(9):734-40. PubMed ID: 27317014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serious bleeding complications caused by warfarin with international normalized ratio 2.1].
    Kierulf-Lassen C; Hvas AM; Poulsen BK
    Ugeskr Laeger; 2015 Jan; 177(2A):52-3. PubMed ID: 25612965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report.
    Sorbera M; Joseph T; DiGregorio RV
    J Pharm Pract; 2017 Oct; 30(5):567-570. PubMed ID: 27543375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.